Abbott (ABT) Sees Q4 Sales Growth in Low-Mid Single-Digit Range
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $103.36 -1.78%
EPS Growth %: +9.2%
Financial Fact:
Diluted Earnings Per Common Share (in dollars per share): -0.22
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +9.2%
Financial Fact:
Diluted Earnings Per Common Share (in dollars per share): -0.22
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Abbott Laboratories (NYSE: ABT) said to see fourth-quarter sales growth in the low-to-mid single-digit range. Comments were made on the company's conference call this morning following
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Zumiez, Inc. (ZUMZ) Misses Q2 EPS by 6c, Misses on Revenue; Offers Q3 Guidance
- UBS Downgrades Ypsomed Holding AG (YPSN:SW) to Neutral
Create E-mail Alert Related Categories
GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
